Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Pear Therapeutics, Inc.

< Previous 1 2 3 Next >
Pear Therapeutics Announces Three New Board Members
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics Announces New 12-Month Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Treated with reSET-O®
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Presents Interim Real-World Data Showing Significant Reductions in Symptoms of Chronic Insomnia, Anxiety and Depression with Somryst® at SLEEP 2022
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics Announces New Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Using reSET® at Six Months
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Announces Health Equity Data Showing Similar Engagement with reSET-O® Across US Geographic Regions Presented at APA Annual Meeting
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics to Host Inaugural Virtual Investor Day on June 6, 2022
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics Reports First Quarter 2022 Financial Results
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics Announces the Inclusion of QuickMD in Its Telehealth Provider Experience Initiative
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics to Participate in the 17th Annual Needham Technology & Media Conference
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics to Participate in the Bank of America 2022 Healthcare Conference
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics to Issue First Quarter 2022 Financial Results on Monday, May 16, 2022
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics to Present at 2022 Rx and Illicit Drug Summit
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics Receives Safer Technologies Program (STeP) Designation from FDA for Product Candidate to Treat Acute and Chronic Pain
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics to Participate in Upcoming Investor Conferences
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics Announces Program to Bring Prescription Digital Therapeutics to Patients in Recovery Through a Telehealth Provider Experience
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics to Participate in Upcoming Investor Event Hosted by Credit Suisse
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics Joins Epic App Orchard to Enable Clinicians to Monitor Prescription Digital Therapeutics
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics Announces Agreement with SoftBank Corp. to Develop a Digital Therapeutic for Sleep/Wake Disorders for the Japanese Market
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics Announces Data from Two Studies Evaluating Prescription Digital Therapeutics (PDTs) for Chronic Insomnia Presented at World Sleep Congress 2022
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics to Host Fourth Quarter and Full Year 2021 Earnings Conference Call and Webcast on March 28, 2022 at 4:30 p.m. Eastern Time
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics Announces New CMS HCPCS Code for Prescription Digital Behavioral Therapy Inclusive of All of Its Commercial Products
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics to Participate in Citi’s 2022 Virtual Healthcare Conference
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics Announces Availability of reSET® and reSET-O® in Spanish
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics Announces State of Michigan to Fund Access to Prescription Digital Therapeutics for Substance Use and Opioid Use Disorders
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics to Participate in 9th Annual BTIG MedTech, Digital Health, Life Science & Diagnostics Conference
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Oklahoma Health Care Authority and Pear Therapeutics Enter into Value-Based Agreement for reSET® and reSET-O®
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics Announces Operational Performance Metrics for Full Year 2021 and Reaffirms Financial and Operational Performance Metrics for Full Year 2022
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics to Further Support Point32Health Members in Recovery from Substance Use Disorders
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
Pear Therapeutics Announces the Acquisition of Two Assets Addressing a Comprehensive Spectrum of Depression Conditions
From Pear Therapeutics, Inc.
Via Business Wire
Tickers PEAR
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.